Treatment of Advanced AIDS Patients With Dextrin Sulfate
Recruitment status was Active, not recruiting
The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in AIDS patients who have failed conventional anti-HIV treatment.
|Study Design:||Endpoint Classification: Safety Study
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Intraperitoneal Dextrin Sulfate in Patients With Advanced HIV Disease: A Phase I Trial|
|Study Start Date:||October 1999|
Patients have intraperitoneal (IP) catheter placement done at study entry. Infusion with the carrier vehicle (icodextrin 4%) begins 2 weeks later, and 2 days after that, treatment with dextrin sulphate (DS) commences. DS is given three times per week. A nurse delivers initial treatments and the patient and caregiver will be trained to give subsequent treatments until DS has been given a total of 8 weeks. Patient evaluations are done regularly during treatment and observation continues for 24 weeks.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004987
|United States, Florida|
|Steinhart Medical Associates|
|Miami, Florida, United States, 33133|